Skip to main content
. 2021 Oct 10;9(5):e00874. doi: 10.1002/prp2.874

TABLE 1.

Demographic characteristics in Asian (Parts A, B, and C) and non‐Asian (Part E) subjects (safety analysis set)

Asian subjects (Parts A, B, C) Napabucasin (mg) Placebo (pooled)
80 mg 160 mg 240 mg 480 mg 720 mg 1200 mg
(N = 1) (N = 1) (N = 9) (N = 9) (N = 9) (N = 9) (N = 14)
Sex (male), n (%) 1 (100.0) 1 (100.0) 6 (66.7) 6 (66.7) 6 (66.7) 6 (66.7) 10 (71.4)
Age (y)
Mean (SD) 21 (N/A) 22 (N/A) 23.9 (5.3) 27.8 (4.3) 24.6 (4.3) 28.0 (5.3) 26.0 (6.2)
Median (range) N/A N/A 21 (20–33) 27 (20–34) 23 (20–31) 26 (23–37) 25 (20–38)
Not Hispanic or Latino ethnicity, n (%) 1 (100.0) 1 (100.0) 9 (100.0) 9 (100.0) 9 (100.0) 9 (100.0) 14 (100.0)
Asian race, n (%) 1 (100.0) 1 (100.0) 9 (100.0) 9 (100.0) 9 (100.0) 9 (100.0) 14 (100.0)
Weight (kg)
Mean (SD) 76.2 (N/A) 61.3 (N/A) 57.1 (4.6) 57.7 (8.5) 56.9 (8.1) 61.4 (3.5) 61.6 (6.8)
Median (range) N/A N/A 55.7 (50.5–64.2) 56.1 (45.1–74.4) 57.9 (45.3–68.8) 61.5 (55.3–66.8) 63.3 (50.4–72.1)
BMI (kg/m2)
Mean (SD) 24.0 (N/A) 22.6 (N/A) 20.7 (1.1) 21.1 (2.2) 20.7 (1.3) 22.0 (1.7) 21.6 (1.7)
Median (range) N/A N/A 20.8 (19.1–22.2) 20.3 (18.6–25.0) 20.8 (19.3–22.9) 22.7 (19.5–24.2) 22.0 (18.9–24.0)
Non‐Asian subjects (Part E) (N = 6) (N = 6) (N = 6)
Sex (male), n (%) 6 (100.0) 6 (100.0) 6 (100.0)
Age (y)
Mean (SD) 22.5 (4.0) 29.2 (7.6) 29.0 (4.3)
Median (range) 24 (22–33) 26.5 (22–40) 30 (23–33)
Hispanic or Latino ethnicity, n (%) 2 (33.3) N/A 1 (16.7)
Not Hispanic or Latino ethnicity, n (%) 4 (66.7) 6 (100.0) 5 (83.3)
Caucasian race, n (%) 6 (100.0) 6 (100.0) 6 (100.0)
Weight (kg)
Mean (SD) 65.0 (7.6) 77.2 (11.0) 75.1 (10.0)
Median (range) 63.5 (58.6–79.6) 78.4 (60.2–90.8) 75.0 (63.0–87.2)
BMI (kg/m2)
Mean (SD) 20.9 (2.4) 22.1 (1.5) 24.0 (2.6)
Median (range) 20.6 (18.3–24.3) 22.7 (19.7–23.7) 23.8 (20.7–27.2)

Abbreviations: BMI, body mass index; N/A, not available; SD, standard deviation.